← Open Payments lookup

ANTHONY SANTALUCIA: Open Payments

NPI 1023596947 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,171 in 47 payments from 11 companies in 2025. Trend: 2023 $1,163 · 2024 $1,092 · 2025 $1,171

Food & beverage: $1,171
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.9$308
Neurocrine BioSciences, Inc.14$293
Vanda Pharmaceuticals Inc.5$181
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$101
Teva Pharmaceuticals USA, Inc.4$70
ABBVIE INC.3$58
Janssen Pharmaceuticals, Inc1$42
E.R. Squibb & Sons, L.L.C.2$41
Takeda Pharmaceuticals U.S.A., Inc.2$32
Lundbeck LLC1$25

Products named: INGREZZA, REXULTI, FANAPT, CAPLYTA, VRAYLAR, ABILIFY MAINTENA, SPRAVATO, COBENFY.

Industry payments across VA — which companies pay providers there.